Cardio Price Sales Ratio from 2010 to 2025

CDIOW Stock  USD 0.06  0.00  0.000002%   
Cardio Diagnostics Price Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price Sales Ratio will likely drop to 2,022 in 2025. During the period from 2010 to 2025, Cardio Diagnostics Price Sales Ratio regression line of quarterly data had mean square error of 9.8 M and geometric mean of  8,264. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
2.1 K
Current Value
K
Quarterly Volatility
4.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cardio Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardio Diagnostics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 134.8 K or Selling General Administrative of 8.4 M, as well as many indicators such as Price To Sales Ratio of 2 K, Dividend Yield of 0.0 or PTB Ratio of 11.67. Cardio financial statements analysis is a perfect complement when working with Cardio Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Cardio Diagnostics Correlation against competitors.

Latest Cardio Diagnostics' Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Cardio Diagnostics Holdings over the last few years. It is Cardio Diagnostics' Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardio Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Slightly volatile
   Price Sales Ratio   
       Timeline  

Cardio Price Sales Ratio Regression Statistics

Arithmetic Mean10,099
Geometric Mean8,264
Coefficient Of Variation45.80
Mean Deviation3,869
Median12,678
Standard Deviation4,625
Sample Variance21.4M
Range10.8K
R-Value(0.76)
Mean Square Error9.8M
R-Squared0.57
Significance0.0007
Slope(734.08)
Total Sum of Squares320.9M

Cardio Price Sales Ratio History

2025 2022.13
2024 2128.56
2023 1850.92
2022 3445.2

About Cardio Diagnostics Financial Statements

Cardio Diagnostics investors use historical fundamental indicators, such as Cardio Diagnostics' Price Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cardio Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Sales Ratio2.1 KK

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardio Stock Analysis

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.